Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury.
about
Mactinin: a modulator of the monocyte response to inflammationPhysiological and pathological roles of tissue plasminogen activator and its inhibitor neuroserpin in the nervous systemBreaking boundaries-coagulation and fibrinolysis at the neurovascular interfacePeripheral glia have a pivotal role in the initial response to axon degeneration of peripheral sensory neurons in zebrafishAcyl-enzyme complexes between tissue-type plasminogen activator and neuroserpin are short-lived in vitroInvolvement of tissue plasminogen activator in onset and effector phases of experimental allergic encephalomyelitisPACAP interacts with PAC1 receptors to induce tissue plasminogen activator (tPA) expression and activity in schwann cell-like culturesLDL receptor-related protein-1: a regulator of inflammation in atherosclerosis, cancer, and injury to the nervous systemTwo conserved regions within the tissue-type plasminogen activator gene promoter mediate regulation by brain-derived neurotrophic factor.Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis.Biodegradable and biocompatible cationic polymer delivering microRNA-221/222 promotes nerve regeneration after sciatic nerve crushThe multiple sclerosis degradome: enzymatic cascades in development and progression of central nervous system inflammatory disease.Fibrinogen signal transduction in the nervous system.Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edemaPharmacological and genetic depletion of fibrinogen protects from kidney fibrosis.Nervous system pathology: the fibrin perspective.Extravascular coagulation and the plasminogen activator/plasmin system in rheumatoid arthritis.Endogenous tissue plasminogen activator mediates bone marrow stromal cell-induced neurite remodeling after stroke in mice.tPA receptors and the fibrinolytic response in multiple sclerosis lesions.A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitisThe unfolded protein response is a major mechanism by which LRP1 regulates Schwann cell survival after injury.Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study.Antithrombotic Effects of Five Organic Extracts of Bangladeshi Plants In Vitro and Mechanisms in In Silico Models.Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice.Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritisMyelin/axonal pathology in interleukin-12 induced serial relapses of experimental allergic encephalomyelitis in the Lewis ratFibrinogen inhibits neurite outgrowth via beta 3 integrin-mediated phosphorylation of the EGF receptorThe Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis.p75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway.The NMDA receptor functions independently and as an LRP1 co-receptor to promote Schwann cell survival and migration.Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease.Laminin gamma1 is critical for Schwann cell differentiation, axon myelination, and regeneration in the peripheral nerveRegulation of cytokine expression by Schwann cells in response to α2-macroglobulin binding to LRP1.A guide to murine fibrinolytic factor structure, function, assays, and genetic alterations.Role of glial cells in axonal regeneration.The sonic hedgehog pathway mediates brain plasticity and subsequent functional recovery after bone marrow stromal cell treatment of stroke in mice.Schwann cell LRP1 regulates remak bundle ultrastructure and axonal interactions to prevent neuropathic pain.Escalated regeneration in sciatic nerve crush injury by the combined therapy of human amniotic fluid mesenchymal stem cells and fermented soybean extracts, Natto.The plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic intervention.Limited regeneration in long acellular nerve allografts is associated with increased Schwann cell senescence.
P2860
Q24795188-D63FB0F8-09E5-499B-BCA5-56EB638B5CA8Q26777276-9A3B87AF-63ED-4513-BD1D-5BC303E85E3EQ26781646-66D50E26-A670-4F95-8EE2-FA20F94619C1Q27317497-39A61E19-7FA8-446A-9D94-14FBE4FFF138Q28201690-27CF0975-FB4C-4C5F-B3D6-02E853BEED42Q28505308-F86939E1-36B5-458B-A579-EFCEFED06069Q28543252-F4C85E0C-4F8A-48A8-B48B-9F1BE825ADA3Q30408735-87901DFC-6296-40C0-A7CA-D274AA3BEE41Q33281559-5265C2B4-1681-4B44-9FA2-68602CA0E3C0Q33696788-14691EF3-6D43-4E2F-81E8-DF7AB42F3E0BQ33807190-C34F18F9-63AE-4375-8139-BCA000C443C0Q33898964-CE174D98-1C01-473E-B648-2C928E5C57C0Q33922746-24DB8029-3266-4EB2-AD3E-3E21BC99EF8EQ34013893-BFA15AC5-1AE0-4D06-92F4-18F8E77F3897Q34062853-2A69908E-8B74-4C3D-8D2C-C58552A398ABQ34584793-528CAC3F-433F-4B74-B967-0D977007177BQ34923078-A8FE2618-0C05-4929-95D6-6805C44FEC81Q34978504-4149988E-820A-4DCD-A9FB-84C943D99D75Q35083789-573BBCA4-FC16-4550-BA6A-2785BCFCEDC5Q35085079-4072554F-A04E-43BD-87A3-E17AD4D2E750Q35283038-BE69DAE6-B9BF-466B-8760-BB0AE8AA84DEQ35485799-3E213A18-FD45-464D-9883-EB38C53A9178Q35667939-6FD574E6-BD1A-42AD-AEDD-1B70F09571EFQ35747177-1609B348-AED2-4B7E-B91A-6AA84E0CFC61Q35788850-3C1B427B-74F9-4F73-8119-69CF46473AEBQ35842235-52612D5B-0313-4E3E-B53F-FB89C730CC2BQ35880183-A78D49D8-3621-4703-B9F4-EC3CEFA02CE7Q36079853-6281D89D-9011-4ECB-AF22-390CD9126960Q36118647-6ADE8473-7C1F-414A-9EA4-2D85882BCD71Q36125572-BDECAFE4-F4C5-4147-B17F-DA0453F0AA61Q36229619-D2ABE386-9E67-4A54-9E47-BF77755E3BFCQ36324885-36BDDAFF-E50A-4663-A8F6-50A7AB8DCC79Q36578185-A53926E4-71A4-4A4D-A11F-F45218ED3D6BQ36777944-AD5B898F-218D-4D37-95AA-14AF9EE6D81CQ36976863-06555F1D-A5D4-4AAB-93DC-8EED32B08A01Q36994328-94743E47-9177-40F7-B823-A87983740717Q37335259-8414BA7B-3F28-456D-86DD-25EB9C0148E9Q37336834-89A60277-F920-4C03-80C3-E46C3E662213Q37366815-12C327B3-6DEC-4657-A0CC-1CAA58734BA2Q37392620-1A30BB68-5E0C-4F75-A2E4-CF3983116FB3
P2860
Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Tissue plasminogen activator-m ...... on after sciatic nerve injury.
@ast
Tissue plasminogen activator-m ...... on after sciatic nerve injury.
@en
type
label
Tissue plasminogen activator-m ...... on after sciatic nerve injury.
@ast
Tissue plasminogen activator-m ...... on after sciatic nerve injury.
@en
prefLabel
Tissue plasminogen activator-m ...... on after sciatic nerve injury.
@ast
Tissue plasminogen activator-m ...... on after sciatic nerve injury.
@en
P2093
P2860
P356
P1476
Tissue plasminogen activator-m ...... ion after sciatic nerve injury
@en
P2093
K W Kombrinck
S Strickland
P2860
P304
P356
10.1083/JCB.149.5.1157
P407
P577
2000-05-01T00:00:00Z